infectious disease

J&J drops phase 2 dengue candidate in latest shift from vaccines

Johnson & Johnson’s deprioritization of its infectious disease pipeline has claimed another victim in the form of its dengue virus vaccine mosnodenvir

James Waldron Oct 4, 2024 10:14am

Roche rolls out 12-virus diagnostic test in Europe

Sep 24, 2024 1:00pm

Inflammatix collects $57M as it awaits FDA review of sepsis test

Sep 12, 2024 11:30am

Karius snares FDA breakthrough tag for infectious disease test

May 16, 2024 7:55am

Novo Nordisk Foundation inks R&D pact for global health issues

May 6, 2024 10:59am

Infectious disease DNA tester Karius nets $100M

May 3, 2024 12:18pm